The aim of this study was to evaluate and compare the efficacy and safety of extralesional subcutaneous triamcinolone and intralesional triamcinolone injection procedure for treatment of chalazia.
Recurrent or multiple chalazia, acutely inflamed lesions and patients with contraindications /previous known ocular side effects of steroids were excluded.
Out of 92 patients who were recruited in the study, 89 completed the follow-up protocol, the remaining 3 patients who did not come for 2nd follow-up visit, were contacted on the phone and asked about the resolution of their chalazia.
Chalazia usually can be treated successfully by simple application of physical therapy.
Chalazia that fail to respond to conservative management may be treated with intralesional steroids.
If, after one-two months of conservative therapy or two-four weeks of intralesional steroid therapy, the chalazia has not resolved, surgical resection is the only recourse.
MATERIALS AND METHODS: 30 patients of the age group between 15 to 40 years having solitary and multiple chalazia present in upper or and lower lids were included in the study after taking informed written consent.
The size, location and number of chalazia were recorded.
The purpose of the present study was to evaluate the safety and efficacy of intralesional triamcinolone acetonide in cases of primary chalazia in 66 consecutive cases.
Most the patients had experienced chronic painless mass and had failed to respond to warm compresses and local antibiotics and chalazia had reached stationary size.
These usually rupture and resolve spontaneously but, as with chalazia, treating the associated blepharitis may reduce the recurrence rate.
It is an effective treatment for chalazia and styes and should be initiated at the onset in order to minimise the risk of persistent lumps, and hence surgical intervention.